Reuters logo
5 个月前
BRIEF-TherapeuticsMD presents positive phase 3 data in two presentations for TX-001HR at ENDO 2017
2017年4月3日 / 晚上8点41分 / 5 个月前

BRIEF-TherapeuticsMD presents positive phase 3 data in two presentations for TX-001HR at ENDO 2017

April 3 (Reuters) - TherapeuticsMD Inc

* TherapeuticsMD presents positive phase 3 data in two presentations for TX-001HR at ENDO 2017

* TherapeuticsMD Inc - Results of replenish trial show positive safety and efficacy of TX-001HR

* TherapeuticsMD - Trial achieved statistically significant, clinically meaningful reduction in both frequency and severity of hot flashes compared to placebo Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below